Threshold Pharmaceuticals Inc (THLD.OQ)
THLD.OQ on NASDAQ Stock Exchange Capital Market
5.34USD
1 Aug 2013
5.34USD
1 Aug 2013
Price Change (% chg)
$-0.09 (-1.57%)
$-0.09 (-1.57%)
Prev Close
$5.42
$5.42
Open
$5.48
$5.48
Day's High
$5.48
$5.48
Day's Low
$5.33
$5.33
Volume
18,224
18,224
Avg. Vol
127,889
127,889
52-wk High
$9.28
$9.28
52-wk Low
$3.95
$3.95
About
Threshold Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs targeting the microenvironment of solid tumors and the bone marrows of some hematologic malignancies (blood cancers) as treatments for patients living with cancer. The Company's hypoxia activated prodrug product... (more)
Overall
| Beta: | 1.85 |
| Market Cap (Mil.): | $306.49 |
| Shares Outstanding (Mil.): | 56.55 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| THLD.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 19.50 | 47.13 | 37.76 |
| EPS (TTM): | 0.28 | -- | -- |
| ROI: | 42.76 | -2.58 | 18.76 |
| ROE: | -- | -2.66 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| AstraZeneca plc (AZN.L) | 3,324.00p | -11.00 |
| Bristol Myers Squibb Co. (BMY.N) | $43.87 | +0.63 |
| Bristol Myers Squibb Co. (BMYMP.PK) | -- | -- |
| Eli Lilly & Co. (LLY.N) | $53.34 | +0.23 |
| GlaxoSmithKline plc (GSK.L) | 1,705.78p | +22.00 |
| Bayer AG (BAYGn.DE) | €89.53 | +2.18 |
| Bayer AG (BAYE.F) | -- | -- |
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
| Johnson & Johnson (JNJ.N) | $93.90 | +0.40 |
| Onyx Pharmaceuticals, Inc. (ONXX.OQ) | $132.80 | +1.50 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Wright Reports
|
$460.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$58.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

